Colgate-Palmolive scored a 100 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Colgate-Palmolive increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Colgate-Palmolive forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Colgate-Palmolive is part of the Global Alliance for Responsible Media and is a corporate partner of the National LGBT Chamber of Commerce (NGLCC). The company provides unconscious bias training for its employees and signed onto a 2015 amicus brief supporting Obergefell v. Hodges, legalizing same-sex marriage. Colgate-Palmolive’s CEO signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace. For these reasons, Colgate-Palmolive receives a High Risk rating.